# Qingchi Capital

> Qingchi Capital is a VC fund backing Health Care, Biotechnology and Medical. See 7 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 7
- Last investment: Jul 2024
- Lead investor: 0%
- Last updated: Aug 2026

Qingchi Capital is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 4 | 57% |
| Biotechnology | 4 | 57% |
| Medical | 3 | 43% |
| Pharmaceutical | 3 | 43% |
| Fitness | 1 | 14% |

10 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 4 | 57% |
| Series A | 2 | 29% |
| Series C | 1 | 14% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Mol Breeding | Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services. | $34.5M | Series B | Jul 30, 2024 |  |
| HC Scientific | HC Scientific is a high-tech enterprise integrating research, development, production and sales of a new biomedical system | $41.2M | Series B | Aug 28, 2023 |  |
| CoJourney | CoJourney is a CDMO platform for gene therapy that combines plasmid, viral vector, and mRNA generation, analysis, and detection. | $30M | Series A | Jun 27, 2023 |  |
| Lupeng Pharmaceutical | Lupeng Pharmaceutical is a clinical-stage company that focuses on the drug discovery and development of novel therapies for cancer treatment. | $35M | Series A | Nov 14, 2022 |  |
| Jinfang Pharmaceutical | Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies. | $77.1M | Series C | Dec 31, 2021 |  |
| Raynovent | Raynovent is a science-driven innovative biotech company. | $39.7M | Series B | Dec 15, 2020 |  |
| Jinfang Pharmaceutical | Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies. | $57.3M | Series B | Aug 03, 2020 |  |

7 of 7 investments shown.

## Co-investors
- [Lake Bleu Capital](https://shizune.co/investors/profile/lake-bleu-capital) — VC Fund, 3 deals together
- [CDH Investments](https://shizune.co/investors/profile/cdh-investments) — VC Fund, 2 deals together
- [Dalton Venture](https://shizune.co/investors/profile/dalton-venture) — VC Fund, 2 deals together
- [Huagai Capital](https://shizune.co/investors/profile/huagai-capital) — VC Fund, 2 deals together
- [Legend Capital](https://shizune.co/investors/profile/legend-capital) — VC Fund, 2 deals together
- [Pan-Lin Capital](https://shizune.co/investors/profile/pan-lin-asset-management) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Qingchi Capital invest in?

Qingchi Capital invests primarily in Health Care, Biotechnology and Medical startups, most often at Series B and Series A stage. Most of the 7 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Qingchi Capital last invest?

The most recent investment recorded for Qingchi Capital closed in Jul 2024. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co